# The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients

> **NCT03139708** · PHASE1 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 5 (actual)

## Conditions studied

- Intraocular Pressure

## Interventions

- **DRUG:** Alphagan
- **DRUG:** Phenylephrine
- **DRUG:** Tropicamide

## Key facts

- **NCT ID:** NCT03139708
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2018-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03139708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03139708, "The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03139708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*